|
KMID : 0043319980210020120
|
|
Archives of Pharmacal Research
1998 Volume.21 No. 2 p.120 ~ p.127
|
|
|
Effects of the Peroxisome Proliferator Ciprofibrate and Prostaglandin F2α Combination Treatment on Second Messengers in Cultured Rat Hepatocytes
|
|
Hong Jin-Tae
Yun Yeo-Pyo
|
|
|
Abstract
|
|
|
|
Peroxisome proliferators induce hepatic peroxisome proliferation and hepatic tumors in rodents. These chemicals increase the expression of the peroxisomal -oxidation pathway and the cytochrome P-450 4A family, which metabolizes lipids, including eicosanoids. Peroxisome proliferators transiently induce increased cell proliferation in vivo. However, peroxisome proliferators are weakly mitogenic and are not co-mitogenic with epidermal growth factor (EGF) in cultured hepatocytes. Earlier study found that the peroxisome proliferator ciprofibrate is cornitogenic with eicosanoids. In order to study possible mechanisms of the comitogenicity of peroxisome proliferator ciprofibrate and eicosanoids’ we hypothesized that the co-mitogenicity may result from synergistic or additive increases of second messengers in mitogenic signal pathways. We therefore examined the effect of the peroxisome proliferator ciprofibrate, prostaglandin () and the combination of ciprofibrate and with or without growth factors on the protein kinase C (PKC) activity, and inositol-1, 4, 5-triphosphate () and intracellular calcium () concentrations in cultured rat hepatocytes. The combination of ciprofibrate and significantly increased particulate PKC activity. The combination of ciprofibrate and also significantly increased EGF, transforming growth factor- () and hepatic growth factor (HGF)-induced particulate PKC activity. The combination of ciprofibrate and greatly increased . However, the increases of PKC activity and by ciprofibrate and alone were much smaller. Neither ciprofibrate or alone nor the combination of ciprofibrate and significantly increased the formation of . The combination of ciprofibrate and , however, blocked the inhibitory effect of on particulate PKC activity and formation of induced by EGF. These results show that co-mitogenicity of the peroxisome proliferator ciprofibrate and eicosanoids may result from the increase in particulate PKC activity and intracellular calcium concentration but not from the formation of .
|
|
|
KEYWORD
|
|
|
Peroxisome proliferator, Ciprofibrate, Prostaglandin F2α, Second messengers
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|